Hemodynamic effects of noninvasive systolic unloading (nitroprusside) and diastolic augmentation (external counterpulsation) in patients with acute myocardial infarction.
D000328:Adult; D000368:Aged; D001243:Assisted Circulation; D001794:Blood Pressure; D002302:Cardiac Output; D003326:Coronary Circulation; D005260:Female; D005292:Ferricyanides / Q000008:administration & dosage / Q000627:therapeutic use*; D006339:Heart Rate; D006439:Hemodynamics; D006801:Humans; D007866:Leg / Q000098:blood supply; D008297:Male; D008722:Methods; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology / Q000628:therapy*; D009206:Myocardium / Q000378:metabolism; D009569:Nitric Oxide / Q000008:administration & dosage / Q000627:therapeutic use; D010101:Oxygen Consumption; D011312:Pressure; D011652:Pulmonary Circulation; D012770:Shock, Cardiogenic / Q000188:drug therapy / Q000503:physiopathology / Q000628:therapy; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use*
D005292:Ferricyanides; D014665:Vasodilator Agents; D009569:Nitric Oxide